Galectin Therapeutics Inc
Galectin Therapeutics Inc (GALT) Implied Volatility Current
GALT's 30 day implied volatility is 129.38%, with an IV Rank of 15.08%. This is a low IV Rank versus the past year, meaning Galectin Therapeutics Inc options are relatively cheap and currently favor buyers. GALT's 30 day historical volatility sits at 74.89%, which means implied volatility is running 54.49 points above historical volatility, as of Nov 18, 2026.
Read more
Tracking GALT implied volatility helps you spot when Galectin Therapeutics Inc options are historically cheap or expensive, and where the best trades are hiding. When GALT IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor GALT implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking GALT IV rank helps you see whether GALT's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis.
Implied Volatility
IV is subdued. Premiums are cheap, favoring buyers.
As of Nov 18, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →